Telemus Capital’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $642K | Buy |
9,534
+581
| +6% | +$39.1K | 0.05% | 208 |
|
|
2023
Q3 | $606K | Buy |
8,953
+1,041
| +13% | +$70.5K | 0.06% | 197 |
|
|
2023
Q2 | $566K | Buy |
7,912
+2,058
| +35% | +$147K | 0.05% | 212 |
|
|
2023
Q1 | $406K | Sell |
5,854
-168
| -3% | -$11.7K | 0.04% | 238 |
|
|
2022
Q4 | $426K | Buy |
6,022
+80
| +1% | +$5.66K | 0.04% | 238 |
|
|
2022
Q3 | $326K | Buy |
+5,942
| New | +$326K | 0.03% | 242 |
|
|
2016
Q4 | – | Sell |
-8,694
| Closed | -$286K | – | 307 |
|
|
2016
Q3 | $286K | Sell |
8,694
-3,891
| -31% | -$128K | 0.03% | 282 |
|
|
2016
Q2 | $380K | Sell |
12,585
-223
| -2% | -$6.73K | 0.05% | 243 |
|
|
2016
Q1 | $361K | Buy |
+12,808
| New | +$361K | 0.06% | 229 |
|